Steven L. Hoerter's Net Worth

$8.16 Million

Estimate Recalculated Sep 8, 2024 07:38PM EST

Who is Steven L. Hoerter?

Steven L. Hoerter has an estimated net worth of $8.16 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Deciphera Pharmaceuticals, Inc., Clovis Oncology, Inc., Ignyta, Inc., and Oric Pharmaceuticals, Inc..

SEC CIK

Steven L. Hoerter's CIK is 0001533451

Past Insider Trading and Trends

2018 was Steven L. Hoerter's most active year for acquiring shares with 14 total transactions. Steven L. Hoerter's most active month to acquire stocks was the month of February. 2018 was Steven L. Hoerter's most active year for disposing of shares, totalling 18 transactions. Steven L. Hoerter's most active month to dispose stocks was the month of February. 2018 saw Steven L. Hoerter paying a total of $1,564,556.00 for 170,942 shares, this is the most they've acquired in one year. In 2018 Steven L. Hoerter cashed out on 114,366 shares for a total of $3,084,493.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28

Chief Commercial Officer

Steven L. Hoerter owns 10,941 units of Common stock which is worth $473,526.48.acquired a total of 67,100 shares in AGIOS PHARMACEUTICALS INC at a cost of $1,962,156.00, Steven also disposed a total of 56,159 shares of AGIOS PHARMACEUTICALS INC equalling to $4,119,613.28.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$53.39
-$272,450.00
10.94K
Mar 1 - Mar 4
Form 4
+18.52%
1.71K
$58.03
-$60,351.20
10.94K
Feb 16 - Feb 19
Form 4
∞
9.23K
$52.82
-$304,718.58
9.23K
Jan 20 - Jan 22
Form 4
—
0
$57.34
-$72,078.00
0
Scheduled
Aug 24
Form 4
—
0
$62.17
-$91,881.00
0
Scheduled
Jul 25
Form 4
—
0
—
—
0
Jul 20
Form 4
—
0
$68.67
-$118,531.00
0
Scheduled
Jun 22
Form 4
—
0
$62.76
-$94,300.00
0
Scheduled
May 23
Form 4
—
0
$62.86
-$94,689.50
0
Scheduled
Apr 23
Form 4
—
0
$62.21
-$92,024.50
0
Scheduled
Mar 22
Form 4
—
0
$59.19
-$79,683.50
0
Scheduled
Feb 22
Form 4
—
0
—
—
0
Feb 16
Form 4/A
—
0
—
—
0
Scheduled
Jan 23
Form 4
—
0
$57.30
-$876,750.00
0
Scheduled
Jan 23
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
Feb 16
Form 3
—
0
—
—
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Sep 4
Form 3
—
0
—
—
0
No matching records found

Deciphera Pharmaceuticals, Inc. (DCPH) No price found

President and CEO

Steven L. Hoerter used to own units in Common Stock but no longer holds any shares there. From 2018 to 2024 Steven L. Hoerter acquired a total of 467,340 shares in Deciphera Pharmaceuticals, Inc. at a cost of $108,331.00, Steven also disposed a total of 467,340 shares of Deciphera Pharmaceuticals, Inc. equalling to $1,957,789.56.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-72.76K
—
—
0
Jun 11
Form 4
—
0
—
—
0
Feb 15
Form 4
+77.79%
31.84K
$15.37
-$471,216.75
72.76K
Dec 12 - Dec 13
Form 4
∞
40.93K
$12.02
-$259,255.68
40.93K
Oct 28 - Oct 30
Form 4
-100.00%
-7.50K
$15.57
-$116,781.75
0
Mar 21
Form 4
-80.02%
-30.05K
$16.00
-$480,720.00
7.5K
Scheduled
Feb 14 - Feb 15
Form 4
-7.74%
-3.15K
$9.11
-$28,696.50
37.55K
Scheduled
Mar 21
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Dec 15
Form 4
-7.18%
-3.15K
$43.02
-$135,499.52
40.7K
Scheduled
Mar 18
Form 4
—
0
—
—
0
Feb 16
Form 4
+2.52%
1.08K
$25.40
$27,381.20
43.84K
Jan 21
Form 4
+0.44%
187
$25.40
$4,749.80
42.77K
Aug 20
Form 4
+0.44%
188
$25.40
$4,775.20
42.58K
Jul 20
Form 4
+0.44%
187
$25.40
$4,749.80
42.39K
Jun 18
Form 4
+0.45%
188
$25.40
$4,775.20
42.2K
May 28
Form 4
+0.45%
187
$25.40
$4,749.80
42.02K
Apr 21
Form 4
-19.56%
-10.17K
$31.45
-$408,469.36
41.83K
Scheduled
Mar 18 - Mar 19
Form 4
—
0
—
—
0
Feb 18
Form 4
∞
52K
—
—
52K
Mar 18
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

Clovis Oncology, Inc. No price found

See Remarks

Steven L. Hoerter used to own units in Common Stock but no longer holds any shares there. In the year 2011 Steven L. Hoerter acquired a total of 60,000 shares in Clovis Oncology, Inc. at a cost of $661,200.00, Steven also disposed a total of 60,000 shares of Clovis Oncology, Inc. equalling to $4,340,600.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$45.51
-$1,379,600.00
0
Scheduled
Mar 5
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
$41.51
-$609,800.00
0
Scheduled
Feb 17
Form 4
—
0
$39.01
-$559,800.00
0
Scheduled
Jan 16
Form 4
—
0
$36.51
-$509,800.00
0
Scheduled
Jan 13
Form 4
—
0
—
—
0
Jan 10
Form 4
—
0
$42.04
-$620,400.00
0
Jun 4
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

Ignyta, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 8
Form 3
—
0
—
—
0
No matching records found